Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6354
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus ; volume:17 ; number:1 ; day:3 ; month:6 ; year:2015 ; pages:1-9 ; date:12.2015
Arthritis Research & Therapy ; 17, Heft 1 (3.6.2015), 1-9, 12.2015
- Urheber
-
Migita, Kiyoshi
Akeda, Yukihiro
Akazawa, Manabu
Tohma, Shigeto
Hirano, Fuminori
Ideguchi, Haruko
Matsumura, Ryutaro
Suematsu, Eiichi
Miyamura, Tomoya
Mori, Shunsuke
Fukui, Takahiro
Izumi, Yasumori
Iwanaga, Nozomi
Tsutani, Hiroshi
Saisyo, Kouichirou
Yamanaka, Takao
Ohshima, Shiro
Sugiyama, Takao
Kawabe, Yojiro
Katayama, Masao
Suenaga, Yasuo
Okamoto, Akira
Ohshima, Hisaji
Okada, Yasumasa
Ichikawa, Kenji
Yoshizawa, Shigeru
Kawakami, Kenji
Matsui, Toshihiro
Furukawa, Hiroshi
Oishi, Kazunori
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-015-0662-x
- URN
-
urn:nbn:de:101:1-2019112020030138539092
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Migita, Kiyoshi
- Akeda, Yukihiro
- Akazawa, Manabu
- Tohma, Shigeto
- Hirano, Fuminori
- Ideguchi, Haruko
- Matsumura, Ryutaro
- Suematsu, Eiichi
- Miyamura, Tomoya
- Mori, Shunsuke
- Fukui, Takahiro
- Izumi, Yasumori
- Iwanaga, Nozomi
- Tsutani, Hiroshi
- Saisyo, Kouichirou
- Yamanaka, Takao
- Ohshima, Shiro
- Sugiyama, Takao
- Kawabe, Yojiro
- Katayama, Masao
- Suenaga, Yasuo
- Okamoto, Akira
- Ohshima, Hisaji
- Okada, Yasumasa
- Ichikawa, Kenji
- Yoshizawa, Shigeru
- Kawakami, Kenji
- Matsui, Toshihiro
- Furukawa, Hiroshi
- Oishi, Kazunori
- SpringerLink (Online service)
Ähnliche Objekte (12)
Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001
Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients
The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double-blinded, randomized, placebo-controlled trial
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
Effect of 23-valent pneumococcal polysaccharide vaccine on medical expenses in Japan
Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials
The effect of age on the response to the pneumococcal polysaccharide vaccine
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases – a longitudinal study
Mortality reduction with 23-valent pneumococcal polysaccharide vaccine: a systematic review and meta-analysis
Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001
Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients
The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double-blinded, randomized, placebo-controlled trial
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
Effect of 23-valent pneumococcal polysaccharide vaccine on medical expenses in Japan
Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials
The effect of age on the response to the pneumococcal polysaccharide vaccine
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases – a longitudinal study
Mortality reduction with 23-valent pneumococcal polysaccharide vaccine: a systematic review and meta-analysis
Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001
Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients
The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double-blinded, randomized, placebo-controlled trial
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
Effect of 23-valent pneumococcal polysaccharide vaccine on medical expenses in Japan
Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials
The effect of age on the response to the pneumococcal polysaccharide vaccine
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases – a longitudinal study